Pharmacokinetics of multivitamins in healthy adults Not Applicable
Conditions
Interventions
Approximately 40 participants will be recruited with a goal of completing 25 in the study.
Familiarization: During the familiarization, participants will be informed about the study and sign informed
undergo a general health screening including having their height, weight, and resting heart rate and blood pressure determined
and, be informed of the general methods of the study.
Experimental 1 Testing: Participants will report to the lab after a 12 hour fast from food, dietary supplements, medications, and intake of all su
Sponsors
Better Being Company
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 18 to 65 years at time of consent; 2. Ability to comply with study procedures; and, 3. Availability to complete study based on durations of individual visits and scheduling requirements.
Exclusion criteria
Exclusion criteria: 1. Presence of a disease or medical condition that could reasonably influence study outcomes or make participation inadvisable; 2. Use of medication that could reasonably influence study outcomes or make participation inadvisable; 3. Inability to abstain from medication, supplement, or substance use during the overnight fast and duration of the study visit; 4. Anticipated inability to provide blood samples (e.g., known difficulty providing blood samples); and/or 5. Currently pregnant or breastfeeding, based on self-report.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood samples will be taken 2, 4, and 6 hours following ingestion of the meal and supplement: 1. Area under the concentration vs. time curve (AUC) 2. Maximum observed concentration (Cmax) 3. Time of maximum observed concentration (Tmax) for each nutrient examined: Vitamins D2/D3, A, E, C, B12, and B9 (Folic Acid), magnesium and iron | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
United States of America
Outcome results
None listed